Abstract: Amphiphilic copolymers of stearic acid (SA)-modified s polysaccharides (BSPs-SA) with three different degrees of substitution (DSs) were synthesized. The effects of DS values on the properties of BSPs-SA nanoparticles were evaluated. Drug state, cytotoxicity, and histological studies were carried out. The affinity ability of bovine serum albumin (BSA) and the BSPs-SA nanoparticles was also characterized utilizing ultraviolet and fluorescence spectroscopy. Besides, the bioavailability and tissue distribution of docetaxel (DTX)-loaded BSPs-SA nanoparticles were also assessed. The results demonstrated that the DS increase of the hydrophobic stearic acid segment increased the negative charge, encapsulation efficiency, and drug-loading capacity while decreasing the critical aggregation concentration value as well as the release rate of docetaxel from the nanoparticles. Docetaxel was encapsulated in nanoparticles at the small molecules or had an amorphous status. The inhibitory capability of DTX-loaded BSPs-SA nanoparticles against 4T1 tumor cells was superior to that of Duopafei. The ultraviolet and fluorescence results exhibited a strong binding affinity between BSPs-SA nanoparticles and bovine serum albumin, but the conformation of bovine serum albumin was not altered. Additionally, the area under the concentration⁻time curve (AUC₀) of DTX-loaded BSPs-SA nanoparticles was about 1.42-fold higher compared with Duopafei in tumor-bearing mice. Docetaxel levels of DTX-loaded BSPs-SA nanoparticles in some organs changed, and more docetaxel accumulated in the liver, spleen, and the tumor compared with Duopafei. The experimental results provided a theoretical guidance for further applications of BSPs-SA conjugates as nanocarriers for delivering anticancer drugs.

In Vitro Anticancer Effects of Doxorubicin Loaded Bsa-Dextran Nanoparticles with Different Molecular Weights of Dextran and Different Dextran Conjugation Degrees

Nanoparticles With Dextran/Chitosan Shell And Bsa/Chitosan Core-Doxorubicin Loading And Delivery

Interactions of Self-Assembled Bletilla S triata Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles.

Green Preparation Process, Characterization and Antitumor Effects of Doxorubicin-Bsa-dextran Nanoparticles.

Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface.

Effects of Degree of Substitution on Stearic Acid-Modified Bletilla Striata Polysaccharides Nanoparticles and Interactions Between Nanoparticles and Bovine Serum Albumin

Effect of Preparation Process of Doxorubicin Albumin Nanoparticles on Physicochemical Properties, in Vitro Release and Pharmacokinetics

Enhanced Tumor Delivery and Antitumor Response of Doxorubicin-Loaded Albumin Nanoparticles Formulated Based on a Schiff Base.

Preparation, Drug Release and Cellular Uptake of Doxorubicin-Loaded Dextran-B-poly(ɛ-caprolactone) Nanoparticles

Doxorubicin and Fe3O4 loaded albumin nanoparticles with folic acid modified dextran surface for tumor diagnosis and therapy

Novel Amphiphilic Dextran Copolymers Nanoparticles for Delivery of Doxorubicin

A Novel Self-Assembly Albumin Nanocarrier for Reducing Doxorubicin-Mediated Cardiotoxicity.

Synthesis of Amphiphilic Dextran-Poly(Lactide) Copolymer and Their Nanoparticles As Doxorubicin Delivery Systems

Synthesis and Antitumor Activity of Stearate-G-dextran Micelles for Intracellular Doxorubicin Delivery.

In Vitro Anticancer Activity of Doxorubicin-Loading Pectin Nanoparticles

Preparation of Doxorubicin Loaded Self-Aggregated Nanoparticles Based on Cholesterol-Modified Glycol Chitosan Conjugate and Its Pharmacokinetics in Rats

The Combined Effects of Size and Surface Chemistry on the Accumulation of Boronic Acid-Rich Protein Nanoparticles in Tumors.

Preparation and in vitro characterizations of doxorubicin-loaded micelles

Acid-sensitive Dextran Prodrug: A Higher Molecular Weight Makes a Better Efficacy.

Balancing Efficacy and Safety of Doxorubicin-Loaded Albumin Nanoparticles Utilizing Ph-Sensitive Doxorubicin-Fatty Acid Prodrugs

Human Serum Albumin-Based Doxorubicin Prodrug Nanoparticles with Tumor Ph-Responsive Aggregation-Enhanced Retention and Reduced Cardiotoxicity.